(±)-J-113397（Cat No.:R036161）is a potent and selective inverse agonist of the cannabinoid receptor CB1. It has been extensively studied for its ability to modulate endocannabinoid signaling pathways, particularly in the context of neurological and metabolic diseases. By binding to CB1 receptors and reducing their activity, (±)-J-113397 can help counteract the effects of excessive CB1 activation, such as those seen in obesity, addiction, and anxiety. Its use in preclinical studies has demonstrated its potential as a therapeutic agent for disorders related to the endocannabinoid system, offering insights into new treatment options.